» Articles » PMID: 28913837

Practical Recommendations for Reporting Fine-Gray Model Analyses for Competing Risk Data

Overview
Journal Stat Med
Publisher Wiley
Specialty Public Health
Date 2017 Sep 16
PMID 28913837
Citations 412
Authors
Affiliations
Soon will be listed here.
Abstract

In survival analysis, a competing risk is an event whose occurrence precludes the occurrence of the primary event of interest. Outcomes in medical research are frequently subject to competing risks. In survival analysis, there are 2 key questions that can be addressed using competing risk regression models: first, which covariates affect the rate at which events occur, and second, which covariates affect the probability of an event occurring over time. The cause-specific hazard model estimates the effect of covariates on the rate at which events occur in subjects who are currently event-free. Subdistribution hazard ratios obtained from the Fine-Gray model describe the relative effect of covariates on the subdistribution hazard function. Hence, the covariates in this model can also be interpreted as having an effect on the cumulative incidence function or on the probability of events occurring over time. We conducted a review of the use and interpretation of the Fine-Gray subdistribution hazard model in articles published in the medical literature in 2015. We found that many authors provided an unclear or incorrect interpretation of the regression coefficients associated with this model. An incorrect and inconsistent interpretation of regression coefficients may lead to confusion when comparing results across different studies. Furthermore, an incorrect interpretation of estimated regression coefficients can result in an incorrect understanding about the magnitude of the association between exposure and the incidence of the outcome. The objective of this article is to clarify how these regression coefficients should be reported and to propose suggestions for interpreting these coefficients.

Citing Articles

Effect of Incident Stroke on Dementia Risk Over 10 Years in a Cohort of Asian American and Non-Latino White Older Adults in California.

Rojas-Saunero L, Zhou Y, Hayes-Larson E, Wu Y, Mobley T, Nianogo R Neurology. 2025; 104(7):e213488.

PMID: 40048680 PMC: 11889460. DOI: 10.1212/WNL.0000000000213488.


Polygenic score integrating neurodegenerative and vascular risk informs dementia risk stratification.

DAoust T, Clocchiatti-Tuozzo S, Rivier C, Mishra A, Hachiya T, Grenier-Boley B Alzheimers Dement. 2025; 21(3):e70014.

PMID: 40042447 PMC: 11881617. DOI: 10.1002/alz.70014.


Temporal trends from HIV diagnosis to ART initiation among adults living with HIV in the Asia-Pacific (2013-2023).

Vu T, Rupasinghe D, Khol V, Chaiwarith R, Tanuma J, Kumarasamy N AIDS Res Ther. 2025; 22(1):29.

PMID: 40038791 PMC: 11881487. DOI: 10.1186/s12981-025-00718-8.


Comparison of seven models for the progression patterns of multiple chronic conditions in longitudinal studies.

Baneshi M, Mishra G, Dobson A BMJ Public Health. 2025; 2(2):e000963.

PMID: 40018552 PMC: 11816716. DOI: 10.1136/bmjph-2024-000963.


Risk of Major Adverse Cardiovascular Events Following Nicotinamide Exposure.

Wheless L, Guennoun R, Michalski-McNeely B, Gonzalez K, Weiss R, Zhang S JAMA Dermatol. 2025; .

PMID: 40009360 PMC: 11866069. DOI: 10.1001/jamadermatol.2025.0001.


References
1.
Feinstein L, Edmonds A, Okitolonda V, Cole S, Van Rie A, Chi B . Implementation and Operational Research: Maternal Combination Antiretroviral Therapy Is Associated With Improved Retention of HIV-Exposed Infants in Kinshasa, Democratic Republic of Congo. J Acquir Immune Defic Syndr. 2015; 69(3):e93-9. PMC: 4506694. DOI: 10.1097/QAI.0000000000000644. View

2.
Wolbers M, Koller M, Witteman J, Steyerberg E . Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology. 2009; 20(4):555-61. DOI: 10.1097/EDE.0b013e3181a39056. View

3.
Austin P, Fine J . Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Stat Med. 2017; 36(27):4391-4400. PMC: 5698744. DOI: 10.1002/sim.7501. View

4.
Boekel N, Schaapveld M, Gietema J, Russell N, Poortmans P, Theuws J . Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors. Int J Radiat Oncol Biol Phys. 2016; 94(5):1061-72. DOI: 10.1016/j.ijrobp.2015.11.040. View

5.
Lau B, Cole S, Gange S . Competing risk regression models for epidemiologic data. Am J Epidemiol. 2009; 170(2):244-56. PMC: 2732996. DOI: 10.1093/aje/kwp107. View